New Phase I Translational Team Science Awards (TTSA) funded July 2017
Kristalyn Gallagher, MD (Surgery) and Xian Chen (Biochemistry & Biophysics) are Co-PIs on a project titled Proteogenomic discovery of patient-specific, phenotypic markers for early diagnosis of invasive lobular carcinoma.
Timothy Gershon, MD (Neurology) and Kirk Wilhelmsen, MD (Genetics) are Co-PIs on a project titled Analyzing clonal diversity to improve risk stratification and therapy for meulloblastoma.
Phase I teams awarded a Phase II grant June 2017
Rich David, MD (Ophthalmology), Matthew Hirsch, PhD (Ophthalmology), and Brian Gilger, DVM, MS received continued funding for their project Prevention of Cornea Graft Rejection using AAV Gene Therapy.
Wesley Burks, MD (Pediatrics), Fernando Pardo-Manuel de Villena, PhD (Genetics), Michael Kulis, PhD (Pediatrics), and Martin Ferris, PhD (Genetics) received continued funding for their project Development and genetic characterization of a translational model of peanut allergy.
If you would like further information about the TTSA awards click here.